Send to

Choose Destination

BCG in the immunotherapy of non-Hodgkin's malignant lymphomas: preliminary results of a controlled trial.


Thirty-three patients exhibiting non-Hodgkin's malignant lymphoma with one or more criteria of poor prognosis and in whom complete remission had been induced by an association of chemo + radio + chemotherapy were randomized to either receive BCG or no further treatment. The present results indicate that BCG may be useful to maintain remission in about one-third of the patients, but these results are not yet significant.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center